Heilbrigðisráðuneyti

105/2021

Reglugerð um (12.) breytingu á reglugerð nr. 233/2001, um ávana- og fíkniefni og önnur eftirlitsskyld efni.

Stofnreglugerð:

1. gr.

Í stað heitisins "heilbrigðis- og tryggingamálaráðherra" í 2. mgr. 2. gr., 1. mgr. 6. gr., á tveimur stöðum í 1. mgr. 7. gr. og í 8. gr. reglugerðarinnar kemur, í viðeigandi beygingarfalli: Lyfjastofnun.

 

2. gr.

Í stað orðsins "ráðherra" á tveimur stöðum í 2. mgr. 2. gr. og í 3. mgr. 7. gr. reglugerðarinnar kemur, í viðeigandi beygingarfalli: Lyfjastofnun.

 

3. gr.

Í stað orðanna "ávísun lyfja og gerð lyfseðla og reglugerð um afgreiðslu lyfseðla, áritun og afhend­ingu lyfja" í 3. mgr. 3. gr. reglugerðarinnar kemur: lyfjaávísanir og afhendingu lyfja, með síðari breytingum.

 

4. gr.

Í stað orðsins "ávísa" í 1. mgr. 4. gr., í fyrirsögn IV. kafla, á þremur stöðum í 1., 2. og 4. mgr. 10. gr., og á tveimur stöðum í 1.-2. mgr. 11. gr. reglugerðarinnar kemur, í viðeigandi beygingarfalli: afgreiða.

 

5. gr.

Eftirfarandi breytingar verða gerðar á 5. mgr. 5. gr. reglugerðarinnar:

  1. Í stað heitisins "heilbrigðis- og tryggingamálaráðuneytinu" kemur: Lyfjastofnun.
  2. Í stað orðsins "ráðuneytið" kemur: Lyfjastofnun.

 

6. gr.

Í stað heitisins "heilbrigðis- og tryggingamálaráðuneytið" í 2. mgr. 6. gr., 2. mgr. 7. gr., 8. gr. og 1. mgr. 9. gr. reglugerðarinnar kemur, í viðeigandi beygingarfalli: Lyfjastofnun.

 

7. gr.

Í stað orðsins "ráðuneytinu" í 1. mgr. 9. gr. reglugerðarinnar kemur: Lyfjastofnun.

 

8. gr.

Í stað orðsins "Lyfjum" í 1. mgr. 10. gr. reglugerðarinnar kemur: Lyf.

 

9. gr.

Í stað orðanna "sé ávísað" í 3. mgr. 10. gr. reglugerðarinnar kemur: megi afgreiða.

 

10. gr.

Í stað orðsins "ávísuðu" í 12. gr. reglugerðarinnar kemur: afgreiddu.

 

11. gr.

Eftirfarandi breytingar verða á eftirtöldum efnum í fylgiskjali I:

 

Efni Annað nafn IUPAC (Alþjóðasamtök um hreina og hagnýta efnafræði) Alþjóða­samningar B Undanþágur og athugasemdir
1,4-butanediol BD butane-1,4-diol   x 5)
4-fluoroamphetamine 4-FA
Para-fluoroamphetamine
PFA		 1-(4-fluorophenyl)propan-2-amine P II    
4'-Fluoro-α-pyrrolidinopentiophenone 4-fluoro-α-PVP, 4F-alfa-PVP 1-(4-fluorophenyl)-2-(1-pyrrolidinyl)-1-pentanone   x  
4-methylethcathinone 4-MEC 2-ethylamino-1-(4-methylphenyl)propan-1-one P II    
5F-AKB-48 5F-APINACA N-(1-adamantyl)-1-(5-fluoropentyl)-1H-indazol-3- carboxamid PII    
5F-MDMB-PINACA 5F-ADB N-(1-methoxycarbonyl-2,2-dimethylpropyl)-1-(5- fluoropentyl)-1H-indazol-3-carboxamid P II    
AB-PINACA   N-[(2S)-1-amino-3-methyl-1-oxobutan-2-yl]-1-pentylindazole-3-carboxamide PII    
Carfentanil Carfentanyl Methyl 4-[(1-oxopropyl)phenylamino]-1-(2-phenylethyl)-4-piperidinecarboxylate N IV    
Ethylphenidate   ethyl 2-phenyl-2-piperidin-2-ylacetate P II    
MDMB-CHMICA   (methyl-2-(1-(cyclohexyl­methyl)-1H-indol-3-carboxamido)-3,3-dimethylbutanoat) PII    
Pentedrone   1-phenyl-2-(methylamino)pentan-1-one P II    

 

12. gr.

Í stað orðanna "1. mgr. 7. gr. lyfjalaga, nr. 93/1994 með síðari breytingum," og "7. mgr. 7. gr. sömu laga" í 4. tölul. í kaflanum "Undanþágur og athugasemdir" í fylgiskjali I kemur á tveimur stöðum: lyfjalögum.

 

13. gr.

Við kaflann "Undanþágur og athugasemdir" í fylgiskjali I bætist við nýr töluliður, sem verður svohljóðandi:

5)    Eftirfarandi er einnig undanþegið innflutnings- og útflutningsleyfi:

  a) Vörur sem heimilt er að markaðssetja hér á landi skv. annarri löggjöf en innihalda efnið í snefilmagni.
  b)   Efnið sjálft ef tilætluð not þess eru til iðnaðarframleiðslu og lokaafurðin sem framleidd er hefur ekki eða er ekki talin hafa geðvirk áhrif og hráefnið getur ekki eða er ekki endurheimt frá lokaafurðinni.

       

 

14. gr.

Eftirfarandi efni bætast við lista í fylgiskjali I:

 

Efni Annað heiti IUPAC (Alþjóðasamtök um hreina og hagnýta efnafræði) og önnur fræðiheiti Alþjóða­ samningar B Undan­þágur/ athuga­semdir
1P-LSD 1-propionyllysergid N,N-diethyl-6-methyl-1-propanoyl-9,10-didehydro­ergoline-8-carboxamide   x  
2-(ethylamino)-1-(3-chlorophenyl)propan-1-one   2-(ethylamino)-1-(3-chlorophenyl)propan-1-one   x  
2-(ethylamino)propio­phenone   2-(ethylamino)-1-phenylpropan-1-one   x  
2,3-DMMC   2,3-dimethylmethcathinone   x  
2,4-DMMC   2,4-dimethylmethcathinone   x  
2,4-DMPPP   1-(2,4-dimethylphenyl)-2-pyrrolidine-1-yl-propan-1-one   x  
2,5-dimethoxy-4-fluoroamphetamine   1-(4-fluoro-2,5-dimethoxy­phenyl)propan-2-amine   x  
2,5-dimethoxy-4-nitroamphetamine   1-(2,5-dimethoxy-4-nitrophenyl)propan-2-amine   x  
25B-NBF   2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-fluorobenzyl)ethanamine   x  
25B-NBOH   2-([2-(4-bromo-2,5-dimethoxy­phenyl)ethyl­amino]methyl)phenol   x  
25C-NBF   2-(4-chloro-2,5-dimethoxi­phenyl)-N-(2-fluoro­benzyl)ethanamine   x  
25E-NBOH   2-[([2-(4-ethyl-2,5-dimethoxi­phenyl)ethyl]amino)methyl]­phenol   x  
25E-NBOMe   2-(4-ethyl-2,5-dimethoxiphenyl)-N-(2-methoxy­benzyl)ethanamine   x  
25G-NBOMe   2-(2,5-dimethoxy-3,4-dimethyl­phenyl)-N-(2-methoxy­benzyl)ethanamine   x  
25I-NB34MD   2-(4-iodo-2,5-dimethoxy­phenyl)-N-[(3,4-methylene­dioxy­phenyl)methyl]ethanamine   x  
25I-NBF   2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-fluorobenzyl)ethanamine   x  
25I-NBMD   2-(4-iodo-2,5-dimethoxy­phenyl)-N-[(2,3-methylene­dioxy­phenyl)methyl]ethanamine   x  
25I-NBOH   2-([2-(4-iodo-2,5-dimethoxy­phenyl)ethyl­amino]methyl)phenol   x  
25N-NBOMe   2-(2,5-dimethoxy-4-nitrophenyl)-N-(2-methoxy­benzyl)ethanamine   x  
2C-B-FLY   2-(8-bromo-2,3,6,7-tetrahydrofuro[2,3-f][1]benzo­furan-4-yl)ethanamine   x  
2C-F*   2,5-dimethoxy-4-fluorophenethylamine  ­ x  
2C-H   2,5-dimethoxyphen­ethylamine   x  
2-Cl-4,5-MDMA   2-chloro-4,5-methylene­dioxymethamphetamine   x  
2-CMC 2-Chloromethcathinone 1-(2-chlorophenyl)-2-(methylamino)-1-propanone   x  
2-MEC   2-methyl-N-ethylcathinone   x  
2-methylacetylfentanyl   N-[1-(2-phenylethyl)piperidin-4-yl]-N-(2-methyl­phenyl)acetamide   x  
2-methylamphetamine 2-MA 1-(2-methylphenyl)propan-2-amine   x  
2-(methylamino)hexano­phenone   2-methylamino-1-phenylhexan-1-one   x  
2-methyl-AP-237   1-[4-(3-phenylprop-2-en-1-yl)-2-methylpiperazin-1-yl]butan-1-one   x  
3,4-DCEC   3,4-dichloroethcathinone   x  
3,4-Dichloro-N,N-cyclohexylmethyl­methcathinone   2-(cyclohexyl(methyl)amino)-1-(3,4-dichloro­phenyl)propan-1-one   x  
3,4-dichloromethylphenidate   methyl-2-(3,4-dichlorophenyl)-2-(piperidin-2-yl)acetate   x  
3,4-Dimethoxy-α-PHP   1-(3,4-dimethoxyphenyl)-2-pyrrolidin-1-ylhexan-1-one   x  
3,4-DMA   3,4-dimethoxy­amphetamine   x  
3,4-methylenedioxy-U-47700   N-[2-(dimethyl­amino)cyclo­hexyl]-N-methyl-2H-1,3-benzodioxol-5-carboxamide   x  
3-bromomethcathinone 3-BMC 1-(3-bromophenyl)-2-(methylamino)propan-1-one   x  
3-Desoxy-MDPV 5-DMFPV 5-dihydrobenzofuran­pyrovalerone   x  
3-Fluorofentanyl   N-(3-fluorophenyl)-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide   x  
3-fluoroethylamphetamine 3-FEA N-ethyl-1-(3-fluorophenyl)propan-2-amine   x  
3-fluorophenmetrazine 3-FPM 2-(3-fluorophenyl)-3-methylmorpholine   x  
3-hydroxyphenazepam   7-bromo-3-hydroxy-5-(2-chlorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one   x  
3-hydroxyphencyclidine 3-HO-PCP 3-[1-(piperidin-1-yl)cyclohexyl]phenol   x  
3-chloroethcathinone 3-CEC 2-(ethylamino)-1-(3-chlorophenyl)propan-1-one   x  
3-methoxyeticyclidine 3-MeO-PCE N-ethyl-1-(3-methoxyphenyl)cyclohexan-1-amine   x  
3-methylcrotonylfentanyl   3-methyl-N-(1-phenethylpiperidin-4-yl)-N-phenylbut-2-enamide   x  
3-methylflephedrone   1-(3-fluorophenyl)-2-(methylamino)propan-1-one   x  
3-phenylpropanoylfentanyl   N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]-3-phenylpropanamide   x  
4,4'-dimethylaminorex 4,4'-DMAR 2-amino-4-methyl-5-(4-methylphenyl)-2-oxazoline P II    
4-AcO-DMT   4-acetoxy-N,N-dimethyltryptamine   x  
4-AcO-MET   4-acetoxy-N-methyl-N-ethyltryptamine   x  
4-anilinopiperidine 4-AP N-phenyl-4-piperidinamine   x  
4-BMC   4-bromomethcathinone   x  
4Br-α-PPP   4-bromo-α-pyrrolidinopropio­phenone   x  
4Br-α-PVP   4-bromo-α-pyrrolidinovalero­phenone   x  
4-CA   4-chloroamphetamine   x  
4-CBC   4-chloro-N-butylcathinone   x  
4-CEC   4-chloroethcathinone   x  
4-CIC   4-chloroisopropylcathinone   x  
4-CMA   4-chloromethamphetamine   x  
4-EMC   1-(4-ethylphenyl)-2-(methylamino)propan-1-one   x  
4-FEC   4-fluoroethcathinone   x  
4-Fluoroethylamphetamine 4-FEA N-ethyl-4-fluoro-α-methyl-benzeneethanamine   x  
4-Fluoro-N-isopropylnorpentedrone   1-(4-fluorophenyl)-2-(1-methylethylamino)pentan-1-one   x  
4-fluorobufedrone   1-(4-fluorophenyl)-2-(methylamino)butan-1-one   x  
4-fluorobutyrfentanyl 4F-BF N-[1-(2-phenylethyl)piperidin-4-yl]-N-(4-fluoro­phenyl)butanamide   x  
4-fluoroisobutyrfentanyl 4F-Ibf, pFIBF N-[1-(2-phenylethyl)piperidin-4-yl]-N-(4-fluorophenyl)-2-methylpropanamide N I    
4-fluoromethylphenidate 4F-MPH methyl-2-(4-fluorophenyl)-2-(piperidin-2-yl)acetate   x  
4F-MDMB-BINACA   methyl-2-[1-(4-fluorobutyl)-1H-indazol-3-carboxamido]-3,3-dimethylbutanoate   x  
4F-NEB*   4-fluoro-N-ethylbuphedrone,2-(ethylamino)-1-(4-fluorophenyl)butan-1-one   x  
4F-NEP   4-fluoro-N-ethylpentedrone   x  
4F-PBP   4-fluoro-α-pyrrolidinobutyro­phenone   x  
4F-α-PHiP 4-fluoro-α-pyrrolidinoiso­hexanophenone 4-methyl-1-(4-fluorophenyl)-2-(pyrrolidin-1-yl)pentan-1-one   x  
4F-α-PHP 4-fluoro-α-pyrrolidino­hexanophenone 1-(4-fluorophenyl)-2-(pyrrolidin-1-yl)hexan-1-one   x  
4-Hydroxymethcathinone   1-(4-hydroxyphenyl)-2-(methylamino)propan-1-one   x  
4-chloro-isobutyrfentanyl Para-chloroisobutyrfentanyl N-(4-chlorophenyl)-2-methyl-N-[1-(2-phenylethyl)-4-piperidinyl]-propanamide   x  
4-chloropentedrone   4-chloro-α-methylaminovalero­phenone   x  
4-MeOPBP*   4'-methoxy-α-pyrrolidinobutio­phenone   x  
4-MeO-PCP   1-[1-(4-methoxy­phenyl)cyclo­hexyl]piperidine   x  
4-MeO-α-PVP   4-methoxy-α-pyrrolidinovalero­phenone   x  
4-methoxybutyrfentanyl 4-MeO-BF N-[1-(2-phenylethyl)piperidin-4-yl]-N-(4-methoxy­phenyl)butanamide   x  
4-methylmethylphenidate   methyl-2-(4-methylphenyl)-2-(piperidin-2-yl)acetate   x  
4-methyl-α-ethylaminopentiophenone   2-(ethylamino)-1-(4-methylphenyl)-1-pentanone   x  
4-methyl-α-PiHP 4-methyl-α-pyrrolidinoiso­hexanophenone 4-methyl-1-(4-methylphenyl)-2-(pyrrolidin-1-yl)pentan-1-one   x  
5Cl-AKB-48   N-(adamantyl)-1-(5-chloropentyl)-1H-indazol-3-carboxamide   x  
5Cl-APINACA   N-(1-adamantyl)-1-(5-chloropentyl)-1H-indazol-3-carboxamide   x  
5Cl-AB-PINACA   N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-chloropentyl)-1H-indazol-3-carboxamide   x  
5-DBFPV   5-dihydrobenzo­furanpyrovalerone   x  
5-EAPB   5-(N-ethyl-2-aminopropyl)benzofuran   x  
5F-AB-PINACA   N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazol-3-carboxamide   x  
5F-ADBICA   N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indol-3-carboxamide   x  
5F-AKB-57   adamantyl-1-(5-fluoropentyl)-1H-indazol-3-carboxylate   x  
5F-AMB-PICA   N-(1-methoxycarbonyl-2-methylpropyl)-1-(5-fluoropentyl)-1H-indol-3-carboxamide   x  
5F-CUMYL-PeGACLONE   2-(2-phenylpropan-2-yl)-5-(5-fluoropentyl)-2,5-dihydro-1H-pyrido[4,3-b]indol-1-one   x  
5F-EDMB-PINACA   ethyl-2-[1-(5-fluoropentyl)-1H-indazol-3-carboxamido]-3,3-dimethylbutanoate   x  
5F-MDMB-PICA   methyl-2-[1-(5-fluoropentyl)-1H-indol-3-carboxamido]-3,3-dimethylbutanoate   x  
5F-PB-22   8-quinolinyl-1-(5-fluoropentyl)-1H-indol-3-carboxylate PII    
5-FUR-144 XLR-11 [1-(5-fluoropentyl)-1H-indol-3-yl](2,2,3,3-tetramethyl­cyclopropyl)methanone PII    
5-MAPDB   1-(2,3-dihydrobenzofuran-5-yl)-N-methylpropan-2-amine   x  
5-MAPDI   1-(2,3-dihydro-1H-inden-5-yl)-N-methylpropan-2-amine   x  
5-MeO-DET   N,N-diethyl-2-(5-methoxy-1H-indol-3-yl)ethanamine   x  
5-MeO-EIPT   5-metoxy-N-ethyl-N-isopropyltryptamine   x  
5-MeO-MALT   N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine   x  
5-MeO-NIPT   N-[2-(5-methoxy-1H-indol-3-yl)ethyl]propan-2-amine   x  
5-Metoksymetylon bk-MMDMA β-keto-5-metoxy-3,4-methylenedioxy­methamphetamine   x  
6-allyl-6-norLSD AL-LAD, 6-allylnorlysergide 6-allyl-N,N-diethyl-9,10-didehydroergolin-8-carboxamide   x  
6-MAM 6-monoacetylmorphine (5α,6α)-7,8-didehydro-4,5-epoxy-17-methyl-morphinan-3,6-diol 6-acetate   x  
6-methoxy-MDA   6-methoxy-3,4-methylenedioxy­amphetamine   x  
AB-CHMINACA   N-(1-aminocarbonyl-2-methylpropyl)-1-(cyclohexylmethyl)-1H-indazol-3-carboxamide PII    
Acetylfentanyl   N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide N I    
A-CHMINACA   N-(1-adamantyl)-1-(cyclohexylmethyl)-1H-indazol-3-carboxamide   x  
Acrylfentanyl ACRYLOYLFENTANYL N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]-2-propenamide N I    
ADB-CHMINACA MAB-CHMINACA N-[(2S)-1-amino-3,3-dimethyl-1-oxobutan-2-yl]-1- (cyclohexylmethyl)-1H-indazole-3-carboxamide P II    
ADB-FUBINACA   N-[1-(aminocarbonyl)-2,2-dimethylpropyl]-1-[(4-fluorophenyl)methyl]-1H-indazol-3-carboxamide P II    
Adinazolam   1-(6-phenyl-8-chloro-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-1-yl)-N,N-dimethyl­methanamine   x 4)
ALD-52   1-acetyl-N,N-diethyl-6-methyl-9,10-didehydro­ergoline-8-carboxamide   x  
AM-2201 chlorine analog   (1-(5-chloropentyl)-1H-indol-3-yl)(naphthalen-1-yl)methanone   x  
AM-2201 N-(3-fluoropentyl) isomer   (1-(3-fluoropentyl)-1H-indol-3-yl)(naphthalen-1-yl)methanone   x  
AM-679   (1-pentyl-1H-indol-3-yl)(2-iodophenyl)methanone   x  
AMB-CHMINACA   methyl-2-([1-(cyclo­hexylmethyl)-1H-indazol-3-carbonyl]amino)-3-methylbutanoate   x  
AMB-FUBINACA MMB-FUBINACA, FUB-AMB N-(1-methoxycarbonyl-2-methylpropyl)-1-(p-fluorobenzyl)-1H-indazol-3-carboxamide PII x  
Apinaca   N-(1-adamantyl)-1-pentyl-1H-indazol-3-carboxamide   x  
Benzodioxole-fentanyl   N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]-2H-1,3-benzodioxole-5-carboxamide   x  
Benzoylbenzylfentanyl   N-(1-benzylpiperid-4-yl)-N-phenylbenzamide   x  
Benzoylecgonin   (1R,2R,3S,5S)-3-benzoyloxy-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid   x  
Benzoylfentanyl   N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]-benzamid   x  
Benzylfentanyl   N-(1-benzylpiperidin-4-yl)-N-phenylpropionamide   x  
bk-2C-B   2-amino-1-(4-bromo-2,5-dimethoxyphenyl)ethanone   x  
bk-3,4-MDPA Propylon β-keto-3,4-methylenedioxy­propylamphetamine   x  
bk-6-metoxy-MDMA N-Methyl-bk-MMDA-2; β-keto-6-metoxy-3,4-methylenedioxy­methamphetamine   x  
bk-IMP   1-(2,3-dihydro-1H-inden-5-yl)-2-(methylamino)propan-1-one   x  
bk-IVP   1-(2,3-dihydro-1-inden-5-yl)-2-(ethylamino)pentan-1-one   x  
bk-MDEA   β-keto-methylenedioxy-N-ethylamphetamine   x  
bk-MDMA   β-keto-3,4-methylenedioxy­methamphetamine P II    
BMDB*   2-benzylamino-1-(3,4-methylenedioxy­phenyl)butan-1-one   x  
BMDP   1-(1,3-benzodioxol-5-yl)-2-(benzylamino)propan-1-one   x  
Bromadoline   4-bromo-N-[2-(dimethyl­amino)cyclohexyl]benzamide   x  
Bromazolam   8-bromo-6-phenyl-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine   x  
Butyrfentanyl   N-phenyl-N-[1-(2-phenyl­ethyl)piperidin-4-yl]butanamide N I    
C30-NBOMe   2-(4-chloro-2,5-dimethoxy­phenyl)-N-(3,4,5-trimethoxy­benzyl)ethanamine   x  
Chloro-isobutyrylfentanyl   N-(2-chlorophenyl)-2-methyl-N-[1-(2-phenylethyl)-4- piperidyl]propanamide
N-(3-chlorophenyl)-2-methyl-N-[1-(2-phenylethyl)-4- piperidyl]propanamide
N-(4-chlorophenyl)-2-methyl-N-[1-(2-phenylethyl)-4- piperidyl]propanamide		   x  
Clonazolam   6-(2-chlorophenyl)-1-methyl-8-nitro-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine   x  
Cloniprazepam   1-(cyclopropylmethyl)-5-(2-chlorophenyl)-7-nitro-1,3-dihydro-2H-[1,4]- benzodiazepin-2-one   x  
CUMYL-4CN-BINACA   N-(1-methyl-1-phenylethyl)-1-(4-cyanobutyl)-1H-indazol-3-carboxamide P II    
CUMYL-5F-P7AICA   N-(2-phenylpropan-2-yl)-1-(5-fluoropentyl)-7-azaindol-3-carboxamid   x  
CUMYL-5F-PINACA   N-(2-phenylpropan-2-yl)-1-(5-fluoropentyl)-1H-indazol-3-carboxamide   x  
CUMYL-CHMGACLONE   5-(cyclohexylmethyl)-2-(2-phenylpropan-2-yl)-2,5-dihydro-1H-pyrido[4,3-b]indol-1-one   x  
CUMYL-PeGACLONE   2-(2-phenylpropan-2-yl)-5-pentyl-2,5-dihydro-1H-pyrido[4,3- b]indol-1-one   x  
CUMYL-PICA   N-(2-phenylpropan-2-yl)-1-pentyl-1H-indol-3-carboxamide   x  
Cyclopentylfentanyl   N-phenyl-N-[1-(2-phenylethyl)-4-piperidyl]cyclo­pentane­carboxamide   x  
Cyclopropylfentanyl   N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]cyclo­propane­carboxamide N I    
Deschloroetizolam   2-ethyl-9-methyl-4-phenyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine   x  
Deschloro-N-ethylnorketamine O-PCE 2-(ethylamino)-2-phenylcyclohexan-1-one   x  
Desoxy-D2PM   2-(diphenyl­methyl)pyrrolidine   x  
Despropionylfluorofentanyl   N-(2-Fluorophenyl)-1-(2-phenylethyl)piperidin-4-amine
N-(3-Fluorophenyl)-1-(2-phenylethyl)piperidin-4-amine
N-(4-Fluorophenyl)-1-(2-phenylethyl)piperidin-4-amine		   x  
Diclazepam   7-chloro-5-(2-chlorophenyl)-1-methyl-1H-benzo[e][1,4]diazepin-2(3H)-one   x  
Dichloropane RTI-111 methyl-3-(3,4-dichlorophenyl)-8-methyl-8-azabicyclo[3.2.1]octan-2-carboxylate   x  
Dimethocaine   [3-(diethylamino)-2,2-dimethylpropyl] 4-aminobenzoate   x  
Dipentylon   1-(1,3-benzodioxol-5-yl)-2-(dimethylamino)pentan-1-one   x  
Diphenidine difenidin 1-(1,2-diphenyl­ethyl)piperidine   x  
DL-4662   1-(3,4-dimethoxyphenyl)-2-(ethylamino)pentan-1-one   x  
DOPR   2,5-dimethoxy-4-propylamphetamine   x  
DOT   2,5-dimethoxy-4-methylthio­amphetamine   x  
Eflea   N-[1-(2,3-dihydro-1,4-benzodioxin-6-yl)propan-2-yl]-N-methylhydroxylamine   x  
Ephenidine   N-ethyl-1,2-diphenyl­ethylamine   x  
Etaqualone   3-(2-ethylphenyl)-2-methylquinazolin-4(3H)-one   x  
ETH-LAD   N,N,6-triethyl-9,10-didehydroergoline-8-carboxamide   x  
Ethylon etylon, ethylone 1-(benzo[d][1,3]dioxol-5-yl)-2-(ethylamino)propan-1-on P II    
Flualprazolam   6-(2-fluorophenyl)-8-chloro-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine   x  
Flubromazepam   7-bromo-5-(2-fluorophenyl)-1H-benzo[e][1,4]diazepin-2(3H)-one   x  
Flubromazolam   8-bromo-6-(2-fluorophenyl)-1-methyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine   x  
Fluorobutyrylfentanyl   N-(2-fluorophenyl)-N-[(1-(2-phenylethyl)-4-piperidinyl)]butanamid
N-(3-fluorophenyl)-N-[(1-(2-phenylethyl)-4-piperidinyl)]butanamid
N-(4-fluorophenyl)-N-[(1-(2-phenylethyl)-4-piperidinyl)]butanamid		   x  
Fluoro-isobutyrylfentanyl   N-(2-fluorophenyl)-2-methyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamid
N-(3-fluorophenyl)-2-methyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamid
N-(4-fluorophenyl)-2-methyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamid		 NI    
FUB-144   (1-(4-fluorobenzyl)-1H-indol-3-yl)(2,2,3,3-tetramethyl­cyclopropyl)methanone   x  
Furanylethylfentanyl   N-[1-[2-(2-furanyl)ethyl]piperidin-4-yl]-N-phenyl-propanamide   x  
Furanylfentanyl   N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]-furan-2-carboxamide N I    
Gamma-Butyrolactone GBL
4-butyrolactone		 oxolan-2-one   x 5)
Hexedrone   2-methylamino-1-phenylhexan-1-one   x  
I-AMB   methyl-2-([1-(5-fluoropentyl)-1H-indol-3-yl]carboxamido)-3- methylbutanoate   x  
isopropylphenidate   Isopropyl-2-phenyl-2-(piperidin-2-yl)acetate   x  
Isopropyl-U-47700   N-[2-(dimethyl­amino)cyclohexyl]-3,4-dichloro-N-(propan-2-yl)benzamide   x  
Isotonitazene   N,N-diethyl-2-[2-(4-isopropoxybenzyl)-5-nitro-1H-benzo[d]imidazol-1- yl]ethan-1-amine   x  
JWH-308   naphthalen-1-yl[5-(4-fluorophenyl)-1-pentyl-1H-pyrrol-3-yl]methanone   x  
JWH-309   naphthalen-1-yl[5-(1-naphthalenyl)-1-pentyl-1H-pyrrol-3-yl]-methanone   x  
JWH-368   naphthalen-1-yl(5-(3-fluorophenyl)-1-pentyl-1H-pyrrol-3-yl)methanone   x  
JWH-369   [5-(2-chlorophenyl)-1-pentyl-1H-pyrrol-3-yl]-1-naphthalenyl-methanone   x  
LSZ   8b-(2,4-dimethylazetidin-1-yl)carbonyl-9,10-didehydro-6-methylergoline   x  
MAM-2201 klór analog   (1-(5-chloropentyl)-1H-indol-3-yl)(4-methylnaphthalen-1-yl)methanone   x  
MAM-2201 N-(3-fluoro­pentyl) analog   (1-(3-fluoropentyl)-1H-indol-3-yl)(4-methylnaphthalen-1-yl)methanone   x  
MDAI 5,6-methylenedioxy-2-aminoindane (6,7-dihydro-5H-cyclo­penta[f][1,3]benzodioxol-6-amine)   x  
MDMB-4en-PINACA   methyl-3,3-dimethyl-2-[1-(pent-4-en-1-yl)-1H-indazol-3- carboxamido]butanoate   x  
MDMB-CHMINACA   methyl-2-([1-(cyclohexyl­methyl)-1H-indazol-3-carbonyl]amino)-3,3-dimethylbutanoate   x  
MDPBP   1-(1,3-benzodioxol-5-yl)-2-(pyrrolidin-1-yl)butan-1-one   x  
MDPHP   1-(1,3-benzodioxol-5-yl)-2-(pyrrolidin-1-yl)hexan-1-one   x  
Meclonazepam   5-(2-chlorophenyl)-3-methyl-7-nitro-1,3-dihydro-2H-[1,4]-benzodiazepin-2-one   x  
MeO-diphenidine   1-(1-(2-methoxyphenyl)-2-phenylethyl)piperidine
1-(1-(3-methoxyphenyl)-2-phenylethyl)piperidine
1-(1-(4-methoxyphenyl)-2-phenylethyl)piperidine		   x  
MeO-PCP   1-(1-(2-methoxy­phenyl)cyclo­hexyl)piperidine
1-(1-(3-methoxy­phenyl)cyclo­hexyl)piperidine
1-(1-(4-methoxy­phenyl)cyclo­hexyl)piperidine		   x  
MET   N-methyl-N-ethyltryptamine   x  
Methacrylfentanyl   N-(1-phenethylpiperidin-4-yl)-N-phenyl­methacrylamide   x  
Methallylescaline MAL 2-[3,5-dimethoxy-4-(2-methylprop-2-enoxy)phenyl]ethanamine   x  
Methamnetamine   N-methyl-1-(naphthalen-2-yl)propan-2-amine   x  
Methoxyacetylfentanyl   2-methoxy-N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide N I    
Methoxybutyrylfentanyl   N-(2-methoxyphenyl)-N-[1-(2-phenylethyl)piperidin-4-yl]butanamid
N-(3-methoxyphenyl)-N-[1-(2-phenylethyl)piperidin-4-yl]butanamid
N-(4-methoxyphenyl)-N-[1-(2-phenylethyl)piperidin-4-yl]butanamid		   x  
Methiopropamine MPA N-methyl-1-(thiophen-2-yl)propan-2-amine P II    
Metizolam   4-(2-chlorophenyl)-2-ethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine   x  
Methylclonazepam   5-(2-chlorophenyl)-1-methyl-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one   x  
Methylnaphthidate HDMP-28 methyl-naphthalen-2-yl(piperidin-2-yl)acetate   x  
MIPT   N-[2-(1H-indol-3-yl)ethyl]-N-methylpropan-2-amine   x  
MMB-022 AMB-4en-PICA methyl-3-methyl-2-[1-(pent-4-en-1-yl)-1H-indol-3-carboxamido]butanoate   x  
MMB-CHMICA AMB-CHMICA methyl-2-[1-(cyclohexyl­methyl)-1H-indol-3-carboxamido]-3- methylbutanoate   x  
MMB-FUBICA AMB-FUBICA, FUB-AMB methyl-2-[1-(4-fluorobenzyl)-1H-indol-3-carboxamido]-3-methylbutanoate P II    
MMDA-2 6-metoxy-MDA 6-methoxy-3,4-methylenedioxy­amphetamine   x  
MOPPP*   4'-methoxy-α-pyrrolidino­proiophenone   x  
MPHP*   4-methylphenyl­pyrrolidinyl­hexanone   x  
MPhP-2201   methyl-3-phenyl-2-[1-(5-fluoropentyl)-1H-indol-3-carboxamido]propanoate   x  
MT-45   1-cyclohexyl-4-(1,2-diphenylethyl)-piperazin N I    
N,N-dimethylpentylon   1-(1,3-benzodioxol-5-yl)-2-(dimethylamino)-1-pentanone   x  
N-ethylhexedrone NEH 2-(ethylamino)-1-phenyl-hexan-1-one   x  
N-ethylisohexedrone   2-(ethylamino)-4-methyl-1-phenyl-pentan-1-one   x  
N-ethylnorketamine   2-(ethylamino)-2-(2-chlorophenyl)cyclohexan-1-one   x  
N-ethylnorpentylone Efylon, ephylone 1-(1,3-benzodioxol-5-yl)-2-(ethylamino)-1-pentanone P II    
N-ethyl-pentedron NEP 2-(ethylamino)-1-phenyl-pentan-1-one   x  
N-hydroxy-MDA N-OH-MDA N-hydroxy-α-methyl-1,3-benzodioxole-5-ethanamine    x  
Nifoxipam 3-hydroxydesmethyl­flunitrazepam 5-(2-fluorophenyl)-3-hydroxy-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one   x  
Nitrazolam   6-phenyl-1-methyl-8-nitro-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine   x  
NM-2201   naphthalen-1-yl-1-(5-fluoropentyl)-1H-indol-3-carboxylate   x  
N-Methyl-2-AI N-metyl-2AI, N-methyl-2-aminoindane N-methyl-2,3-dihydro-1H-inden-2-amine   x  
Norfentanyl   N-phenyl-N-(piperidin-4-yl)propionamide   x  
Norfludiazepam   5-(2-fluorophenyl)-7-chloro-1,3-dihydro-2H-1,4-benzodiazepin-2-one   x  
N-Propylnorpentedrone   1-phenyl-2-(propylamino)pentan-1-one   x  
Ocfentanil ocfentanyl N-(2-fluorophenyl)-2-methoxy-N-(1-phenethylpiperidin-4-yl)acetamide N I    
Orthoflurorofentanyl 2-fluorofentanyl N-[1-(2-phenylethyl)piperidin-4-yl]-N-(2-fluorophenyl)pro­panamide N I    
Parafluorobutyrylfentanyl   N-(4-fluorophenyl)-N-[1-(2-phenylethyl)piperidin-4- yl]butanamide N I    
Pentylone   1-(1,3-benzodioxol-5-yl)-2-(metylamino)pentan-1-one   x  
p-MePPP   1-(4-methylphenyl)-2-(pyrrolidin-1-yl)propan-1-one   x  
Pregabalin   (3S)-3-(aminomethyl)-5-methylhexanoic acid   x 4)
Propylphenidate   propyl-2-phenyl-2-(piperidin-2-yl)acetate   x  
Proscaline 4-Propoxy-3,5-DMPEA
proscaline		 3,5-dimethoxy-4-propoxyphenethylamine   x  
PV9 α-POP 1-phenyl-2-(pyrrolidin-1-yl)octan-1-one   x  
Pyrazolam   8-bromo-1-methyl-6-(pyridin-2-yl)-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine   x  
SDB-001   N-(1-adamantyl)-1-pentyl-1H-indol-3-carboxamide   x  
SDB-006   N-benzyl-1-pentyl-1H-indol-3-carboxamide   x  
Senecioylfentanyl β'-methyl Crotonyl fentanyl,
3,3-Dimethylacrylfentanyl		 3-methyl-N-(1-phenethylpiperidin-4-yl)-N-phenylbut-2-enamide   x  
SL-164   5-chloro-3-(4-chloro-2-methylphenyl)-2-methylquinazolin-4(3H)-one   x  
STS-135   N-(1-adamantyl)-1-(5-fluoropentyl)-1H-indol-3-carboxamide   x  
Tetrahydrofuranyl­fentanyl tetrahydrofuranfentanyl,
THF-F		 N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]tetrahydrofuran-2-carboxamide N I    
Tetramethyl­cyclopropyl­fentanyl   N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]-2,2,3,3-tetramethylcyclo­propane-1-carboxamide   x  
THJ-2201   (1-(5-fluoropentyl)-1H-indazol-3-yl)(naphthalen-1-yl)methanone   x  
TH-PHP   2-(pyrrolidin-1-yl)-1-(5,6,7,8-tetrahydronaphthalen-2-yl)hexan-1-one   x  
TH-PVP   2-(pyrrolidin-1-yl)-1-(5,6,7,8-tetrahydronaphthalen-2-yl)pentan-1-one   x  
Thiafentanil   methyl-4-[phenyl(methoxy­acetyl)amino]-1-[2-(2-thienyl)ethyl]piperidin-4-carboxylate   x  
Tiletamine   2-(ethylamino)-2-(thiophen-2-yl)cyclohexan-1-one   x  
U-47700   3,4-dichlor-N-(2-(dimethyl­amino)cyclohexyl)-N-methylbenzamide N I    
U-49900   N-[2-(diethyl­amino)cyclohexyl]-3,4-dichloro-N-methylbenzamide   x  
UR-144   (1-pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclo­propyl)methanone PII    
Valerylfentanyl   N-phenyl-N-[1-(2-phenylethyl)-4-piperidyl]pentanamid   x  
W-15   4-chloro-N-(1-(2-phenylethyl)-piperidin-2-ylidene)benzene­sulfonamide   x  
W-18   4-chloro-N-(1-[2-(4-nitrophenyl)ethyl]piperidin-2-ylidene)benzenesulfonamide   x  
Zapizolam   8-chloro-6-(2-chlorophenyl)-4H-pyrido[2,3-f][1,2,4]triazolo[4,3-a][1,4]diazepine   x  
α-diethylmethylamino­pentiophenone   1-fenyl-2-(1-metyl­etylamino)pentan-1-on   x  
α-Dimethylaminopentio­phenone       x  
α-EPP   α-ethylaminopentiophenone   x  
α-PCYP   2-cyclohexyl-1-phenyl-2-(pyrrolidin-1-yl)ethan-1-one   x  
α-PEP   1-phenyl-2-(pyrrolidin-1-yl)heptan-1-one   x  
α-PHP   1-phenyl-2-(pyrrolidin-1-yl)hexan-1-one   x  
α-PHPP   α-pyrrolidinoheptophenone   x  
α-PNP   1-phenyl-2-(pyrrolidin-1-yl)nonan-1-one   x  
α-POP   1-phenyl-2-(pyrrolidin-1-yl)octan-1-one   x  
α-TMT   α-N,N-trimetyltryptamin   x  
β-hydroxy-3-methylfentanyl   N-[1-(β-hydroxyphenethyl)-3-methyl-4-piperidyl]propionanilide N I + IV    

 

15. gr.

Við töflu í fylgiskjali II bætast eftirtalin efni:

 

Efni Annað nafn D I - II Hámark án innflutningsleyfis
3,4-MDP-2-P methyl glycidate   D I  
3,4-MDP-2-P methyl glycidic acid   D I  
alpha-Phenylacetoacetamide APAA D I  

 

16. gr.

Gildistaka.

Reglugerð þessi, sem er sett með heimild í 53. gr. lyfjalaga nr. 100/2020 og 2. gr. laga um ávana- og fíkniefni nr. 65/1974 með síðari breytingum, öðlast þegar gildi.

Reglugerð þessi hefur verið tilkynnt í samræmi við ákvæði tilskipunar ESB 2015/1535 sem setur reglur um tilhögun upplýsingaskipta vegna tæknilegra reglna.

 

Heilbrigðisráðuneytinu, 20. janúar 2021.

 

F. h. r.

Ásta Valdimarsdóttir.

Hrönn Ottósdóttir.

Þetta vefsvæði byggir á Eplica